Skip to content

Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome

SafEE : Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02288221
Acronym
SafEE
Enrollment
4
Registered
2014-11-11
Start date
2015-06-04
Completion date
2017-07-05
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Deterioration

Brief summary

All over the world the increasing prevalence of chronic disorders and its impact on functional decline is challenging the sustainability of health care systems. Older individuals also frequently experience the reversible frailty syndrome, which overlaps with chronic diseases, increasing incidence of disability. Building a global system aiming to take in charge all causes leading to loss of autonomy is a rather complicated task involving numerous Information and Communication technologies (ICT) solutions which are not always easy to use in everyday life. The SafEE (Safe Easy Environment) project aim is to improve the safety, autonomy and quality of life of older people at risk. The SafEE project develop non pharmacological therapeutic through diferent ICT (stimulation aromatherapy automatic fragrance, training interface based on Kinect sensor...) . The goal of this study is to validate the acceptability, sensitivity and efficacy of the systems.

Detailed description

The non pharmacological therapeutic will be install at patient's home : * aromatherapy, * music therapy, * cognitive training in multimedia application offering cognitive games. Also smart phone will be given to the patient : * to help him move with a geolocation application, * to remind him of his daily needs (shopping lists, people to call, etc ...) with an alert apllication.

Interventions

Installation at patient's home of : * aromatherapy * music therapy * cognitive training in multimedia application offering cognitive games

OTHERPatient's answer without non pharmacological therapeutic

No installation at patient's home

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female age ≥ 60 years with memory complaint * Score at the Mini Mental Test (MMSE) ≥ 26. * Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5.

Exclusion criteria

* Sensory defect (visual or olfactory) preventing the patient to perfectly meet therapeutic solutions. * Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment. * Subject epileptic. * Subject vulnerable

Design outcomes

Primary

MeasureTime frame
Time spent by the patient using the non-therapeutic solutions6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026